Avantor, Inc. (NYSE:AVTR) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Avantor, Inc. (NYSE:AVTRGet Rating) have been assigned a consensus rating of “Moderate Buy” from the sixteen brokerages that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $37.62.

A number of analysts have commented on AVTR shares. Barclays dropped their price target on shares of Avantor to $33.00 in a research report on Tuesday, August 9th. Morgan Stanley lowered their price objective on shares of Avantor from $40.00 to $37.00 and set an “overweight” rating on the stock in a research note on Monday, August 1st. TheStreet raised shares of Avantor from a “c” rating to a “b-” rating in a research note on Thursday, May 19th. Citigroup dropped their target price on shares of Avantor from $38.00 to $32.00 and set a “neutral” rating on the stock in a research report on Monday, August 1st. Finally, Robert W. Baird dropped their target price on shares of Avantor from $44.00 to $34.00 and set an “outperform” rating on the stock in a research report on Monday, August 1st.

Institutional Trading of Avantor

Institutional investors have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its stake in shares of Avantor by 3.8% in the second quarter. Price T Rowe Associates Inc. MD now owns 86,156,553 shares of the company’s stock worth $2,679,469,000 after buying an additional 3,164,276 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Avantor by 0.9% in the first quarter. Vanguard Group Inc. now owns 50,759,035 shares of the company’s stock worth $1,716,671,000 after buying an additional 439,147 shares during the last quarter. Canada Pension Plan Investment Board lifted its stake in shares of Avantor by 9.9% in the fourth quarter. Canada Pension Plan Investment Board now owns 24,950,296 shares of the company’s stock worth $1,051,405,000 after buying an additional 2,251,340 shares during the last quarter. Boston Partners lifted its stake in shares of Avantor by 4.3% in the first quarter. Boston Partners now owns 19,771,940 shares of the company’s stock worth $668,176,000 after buying an additional 806,442 shares during the last quarter. Finally, Allianz Asset Management GmbH lifted its stake in shares of Avantor by 43.5% in the second quarter. Allianz Asset Management GmbH now owns 12,708,479 shares of the company’s stock worth $395,233,000 after buying an additional 3,854,096 shares during the last quarter. 81.22% of the stock is currently owned by institutional investors and hedge funds.

Avantor Trading Down 1.7 %

Avantor stock opened at $24.50 on Monday. The firm’s 50-day moving average is $29.16 and its 200-day moving average is $31.24. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.05 and a current ratio of 1.64. Avantor has a 1 year low of $24.42 and a 1 year high of $44.37. The company has a market cap of $16.51 billion, a P/E ratio of 26.34, a PEG ratio of 2.20 and a beta of 1.30.

Avantor (NYSE:AVTRGet Rating) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.01). Avantor had a net margin of 8.27% and a return on equity of 27.14%. The firm had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.98 billion. During the same quarter in the prior year, the business earned $0.35 earnings per share. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. On average, equities analysts expect that Avantor will post 1.46 earnings per share for the current year.

Avantor Company Profile

(Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Analyst Recommendations for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.